11.07.2015 Views

Novel genetic and epigenetic alterations in ... - Ous-research.no

Novel genetic and epigenetic alterations in ... - Ous-research.no

Novel genetic and epigenetic alterations in ... - Ous-research.no

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Discussiondepends on the requirement. Direct sequenc<strong>in</strong>g of human tumors can lead to anunderestimation of the methylation at CpG sites, s<strong>in</strong>ce tumor samples often areheterogeneous <strong>and</strong> may conta<strong>in</strong> <strong>no</strong>rmal cells which <strong>in</strong> most cases are unmethylated for thegene <strong>in</strong> question.Bisulfite sequenc<strong>in</strong>g is an important validation analysis that will reveal how representative theresults from each of the MSP assays are. In Paper Ib, we found hypermethylation of theMAL promoter <strong>in</strong> ~80% of colorectal carc<strong>in</strong>omas (Paper Ia <strong>and</strong> Ib) us<strong>in</strong>g MSP, whilea<strong>no</strong>ther study (Mori et al) reported only 6% for the same gene[132]. The primers used <strong>in</strong> ourMSP study were located very close to the transcription site while the other study usedprimers located a couple of hundred base pairs upstream. Bisulfite sequenc<strong>in</strong>g clearlyshowed that methylation is unequally distributed with<strong>in</strong> the MAL promoter. A goodassociation between methylation status, as assessed by MSP, <strong>and</strong> the bisulfite sequences ofthe overlapp<strong>in</strong>g fragment for the MSP product located close to transcription start site(fragment A) was seen. In contrast, the region reported <strong>in</strong> the Mori study[132] was generallyunmethylated <strong>in</strong> the same cell l<strong>in</strong>e panel. Sequence data showed that only a m<strong>in</strong>ority of theCpG sites covered by the Mori antisense primer were methylated <strong>in</strong> the 19 colon cancer celll<strong>in</strong>es analyzed, despite the fact that these were heavily methylated around the transcriptionstart site. The CpG sites analyzed by the Mori primer set were therefore <strong>no</strong>t representativefor the methylation status of the promoter, lead<strong>in</strong>g to false negative results <strong>and</strong> anunderestimation of the methylation load of MAL. This f<strong>in</strong>d<strong>in</strong>g illustrates the importance ofcomb<strong>in</strong><strong>in</strong>g MSP <strong>and</strong> bisulfite sequenc<strong>in</strong>g when analyz<strong>in</strong>g new genes.Mutation analysesInnumerable methods for mutation detection are developed, <strong>and</strong> the methods can be divided<strong>in</strong>to two crude categories, scann<strong>in</strong>g methods <strong>and</strong> diag<strong>no</strong>stic methods. In general, adiag<strong>no</strong>stic method detects <strong>and</strong> identifies mutations <strong>in</strong> one analysis, while a scann<strong>in</strong>g methoddetects sequence <strong>alterations</strong> without describ<strong>in</strong>g the mutation. Therefore, scann<strong>in</strong>g methodsare often comb<strong>in</strong>ed with a second step that identifies the mutation [18].47

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!